Skip to main content

Table 2 Clinical data of the 143 patients with breast cancer

From: The association of infrared imaging findings of the breast with prognosis in breast cancer patients: an observational cohort study

Variable N (%)
Menopausal status
 Premenopausal 45 (31.5)
 Postmenopausal 98 (68.5)
Bilateral breast cancer 7 (5)
Clinical stage
 Stage I and II 101 (70.6)
 Stage III 31 (21.7)
 Stage IV 11 (7.7)
Molecular subtype
 ER/PR-positive, HER2-negative 78 (54.5)
 HER2-positive 32 (22.4)
 Triple negative 33 (23.1)
Histology types
Invasive ductal carcinoma 130 (90.9)
 Grade 1 15 (10.5)
 Grade 2 68 (47.5)
 Grade 3 39 (27.3)
 Unknown 8 (5.6)
Other cancer types
 Invasive lobular carcinoma 8 (5.6)
 Apocrine carcinoma 1 (0.7)
 Mucinous carcinoma 1 (0.7)
 Intracystic papillary carcinoma 2 (1.4)
 Metaplastic carcinoma 1 (0.7)
  1. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2